Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meta Roestenberg

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Immunotherapy Advances|August 4, 2023
Establishing a single-sex controlled human <i>Schistosoma mansoni</i> infection model for Uganda: protocol for safety and dose-finding trialAndrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.
Frontiers in Immunology|January 1, 2026
Temporal modulation of gene expression in a controlled <i>Schistosoma mansoni</i> human infection modelDawei Li, Chuan Jiang, Wenyu Zhu, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 3, 2024
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting reportNicoletta Corti, Christopher Chiu, Rebecca J Cox, et al.
The Journal of Infectious Diseases|June 16, 2018
Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection ModelJacqueline J Janse, Marijke C C Langenberg, Janneke Kos-Van Oosterhoud, et al.
FEMS Microbes|March 5, 2026
Characterization of the clade 4 non-toxigenic <i>C. difficile</i> isolate L-NTCD03 carrying the <i>cfr</i>(B) geneBritt Nibbering, Sam Nooij, Céline Harmanus, et al.
The Journal of Clinical Investigation|December 12, 2024
Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infectionJan Pieter R Koopman, Emma L Houlder, Jacqueline J Janse, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
Nature Communications|July 24, 2025
T cell responses in repeated controlled human schistosome infection compared to natural exposureEmmanuella Driciru, Jan Pieter R Koopman, Sanne Steenbergen, et al.
The Journal of Infectious Diseases|November 29, 2012
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infectionsAnne C Teirlinck, Meta Roestenberg, Marga van de Vegte-Bolmer, et al.
The Journal of Infectious Diseases|May 12, 2019
New Insights Into the Kinetics and Variability of Egg Excretion in Controlled Human Hookworm InfectionsMarie-Astrid Hoogerwerf, Luc E Coffeng, Eric A T Brienen, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Immunotherapy Advances|August 4, 2023
Establishing a single-sex controlled human <i>Schistosoma mansoni</i> infection model for Uganda: protocol for safety and dose-finding trialAndrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.
Frontiers in Immunology|January 1, 2026
Temporal modulation of gene expression in a controlled <i>Schistosoma mansoni</i> human infection modelDawei Li, Chuan Jiang, Wenyu Zhu, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 3, 2024
Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting reportNicoletta Corti, Christopher Chiu, Rebecca J Cox, et al.
The Journal of Infectious Diseases|June 16, 2018
Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection ModelJacqueline J Janse, Marijke C C Langenberg, Janneke Kos-Van Oosterhoud, et al.
FEMS Microbes|March 5, 2026
Characterization of the clade 4 non-toxigenic <i>C. difficile</i> isolate L-NTCD03 carrying the <i>cfr</i>(B) geneBritt Nibbering, Sam Nooij, Céline Harmanus, et al.
The Journal of Clinical Investigation|December 12, 2024
Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infectionJan Pieter R Koopman, Emma L Houlder, Jacqueline J Janse, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
Nature Communications|July 24, 2025
T cell responses in repeated controlled human schistosome infection compared to natural exposureEmmanuella Driciru, Jan Pieter R Koopman, Sanne Steenbergen, et al.
The Journal of Infectious Diseases|November 29, 2012
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infectionsAnne C Teirlinck, Meta Roestenberg, Marga van de Vegte-Bolmer, et al.
The Journal of Infectious Diseases|May 12, 2019
New Insights Into the Kinetics and Variability of Egg Excretion in Controlled Human Hookworm InfectionsMarie-Astrid Hoogerwerf, Luc E Coffeng, Eric A T Brienen, et al.
Pageof 13